Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the Turbuhaler in asthmatic individuals

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 8 I, 2001, Pages 1398-1402

  Derom, Eric ^a   Borgström, Lars ^b   Van Schoor, Jan ^b   Löfroos, Ann Britt ^b   Pauwels, Romain ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

Adrenergic agonists; Antiasthmatic agents; Bronchial asthma; Drug aerosol therapy

Indexed keywords

HISTAMINE; METHACHOLINE; TERBUTALINE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALER; MALE; METERED DOSE INHALER; PRIORITY JOURNAL; PROTECTION; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0035888682     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.8.2101010     Document Type: Article

References (38)

1. Dose-response curves to inhaled beta-adrenoceptot agonists in normal and asthmatic subjects
2. Efficacy and safety of inhaled corticosteroids. New developments
3. Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs?
4. The inhalation device influences lung deposition and bronchodilating effect of terbutaline
5. Autoradiographic localization of autonomic receptors in airway smooth muscle. Marked differences between large and small airways
6. Serial distribution of bronchoconstriction in normal subjects. Methacholine versus histamine
7. Localization of the site of the bronchoconstrictor effects of leukotriene C4 compared with that of histamine in asthmatic subjects
8. Metaproterenol responsiveness after methacholine- and histamine-induced bronchoconstriction
9. Bronchial reactivity to inhaled histamine: A method and clinical survey
10. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours
11. Measurement of responsiveness to inhaled histamine: Comparison of FEV1 and SGaw
12. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults
13. Home assessment of peak inspiratory flow through the Turbohaler in asthmatic patients
14. A method for determination of the absolute pulmonary bioavailability of inhaled drugs: Terbutaline
15. Comparative pharmacokinetlcs of unlabeled and deuterium-labeled terbutaline: Demonstration of a small isotope effect
16. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution
17. The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma
18. Determining equivalence of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at Royal Brompton National Heart & Lung Institute, London 24 June 1994
19. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers
20. Understanding regional lung deposition data in gamma scintigraphy
21. Changing patterns of aerosol deposition during methacholine bronchoprovocation
22. Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler
23. A method for comparing the peak intensity and duration of action of aerosolized bronchodilators using bronchoprovocation with methacholine
24. Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers
25. Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma
26. Histamine and asthma
27. A comparison of histamine, methacholine, and exercise airway reactivity in normal and asthmatic subjects
28. Airway responsiveness to histamine and methacholine: Relationship to minimum treatment to control symptoms of asthma
29. Reproducibility and comparison of responses to inhaled histamine and methacholine
30. Bronchial responsiveness to histamine or methacholine in asthma: Measurement and clinical significance
31. The effect of ipratropium and fenoterol on methacholine-histamine-induced bronchoconstriction
32. Time course of the bronchoconstriction induced by inhaled histamine and methacholine
33. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma
34. Airway calibre as a confounder in interpreting bronchial responsiveness in asthma
35. 1 and bronchial responsiveness in patients with asthma
36. Tachyphylaxis to inhaled histamine in asthmatic subjects
37. Tolerance to methacholine inhalation challenge in nonasthmatic subjects
38. Tachyphylaxis to inhaled methacholine in normal but not asthmatic subjects